Vaccines
| June 1, 2011
Looking back, looking ahead
Advertisement
The Scientist
Most Recent
Successful vaccines have been created to protect against pathogenic bacteria and viruses. Why aren’t there any for combating fungal infections?
It may be time to reconsider an AIDS vaccine which is more human than viral, triggering the immune system in a way that no other vaccine does.
A new breed of vaccines aims to wean users off cocaine.
Decades of vaccine research have expanded our understanding of the immune system and are yielding novel disease-fighting tactics.
Agribusiness giant Monsanto is finding out that it's difficult to conduct field trials of drought-resistant corn when it won't stop raining. The company hopes to launch a new line of corn seed that's been genetically engineered to thrive in drough
The Human Genome Project has generated nearly $800 billion in economic output and hundreds of thousands of jobs in genomics and related industries
By forging new relationships and finding novel uses for existing technologies, this year’s top companies are employing creative ways to advance their science.
Follow The Scientist
Stay Connected with The Scientist
-
The Scientist Magazine
-
The Scientist Careers
-
Neuroscience Research Techniques
-
Genetic Research Techniques
-
Cell Culture Techniques
-
Microbiology and Immunology
-
Cancer Research and Technology
Advertisement
Current Issue
